Clínica universidad de Navarra — Madrid

Public research footprint of Clínica universidad de Navarra, compiled from the ClinicalTrials.gov public registry.

175

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Multiple Myeloma · Relapsed/Refractory Follicular Lymphoma · Advanced Solid Tumor · Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Recently updated registry entries

NCT05184088 — Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis (Completed)
NCT07173751 — ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative… (Recruiting)
NCT03108495 — Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients… (Terminated)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Clínica universidad de Navarra?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.